User profiles for "author:Cindy Ke Zhou"

Cindy Ke Zhou, PhD

Epidemiologist
Verified email at gwmail.gwu.edu
Cited by 1298

TMPRSS2:ERG Gene Fusions in Prostate Cancer of West African Men and a Meta-Analysis of Racial Differences

CK Zhou, D Young, ED Yeboah… - American journal of …, 2017 - academic.oup.com
The prevalence of fusions of the transmembrane protease, serine 2, gene (TMPRSS2) with
the erythroblast transformation-specific–related gene (ERG), or TMPRSS2: ERG, in prostate …

Prostate cancer incidence in 43 populations worldwide: an analysis of time trends overall and by age group

CK Zhou, DP Check, J Lortet‐Tieulent… - … journal of cancer, 2016 - Wiley Online Library
Prostate cancer is a significant public health burden and a major cause of morbidity and
mortality among men worldwide. Analyzing geographic patterns and temporal trends may …

Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases

HL Wong, M Hu, CK Zhou, PC Lloyd, KL Amend… - The Lancet, 2022 - thelancet.com
Background Several passive surveillance systems reported increased risks of myocarditis or
pericarditis, or both, after COVID-19 mRNA vaccination, especially in young men. We used …

[HTML][HTML] Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies

TJ Key, PN Appleby, RC Travis, D Albanes… - The American journal of …, 2015 - Elsevier
Background: Individual studies have suggested that circulating carotenoids, retinol, or
tocopherols may be associated with prostate cancer risk, but the studies have not been large …

[HTML][HTML] mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States

HF Tseng, BK Ackerson, LS Sy, JE Tubert… - Nature …, 2023 - nature.com
The bivalent (original and Omicron BA. 4/BA. 5) mRNA-1273 COVID-19 vaccine was
authorized to offer broader protection against COVID-19. We conducted a matched cohort …

[HTML][HTML] Multi-center matched cohort study of convalescent plasma for hospitalized patients with COVID-19

CK Zhou, MM Bennett, CH Villa, KP Hammonds, Y Lu… - Plos one, 2022 - journals.plos.org
Background Although frequently used in the early pandemic, data on the effectiveness of
COVID-19 convalescent plasma (CCP) remain mixed. We investigated the effectiveness and …

[HTML][HTML] Worldwide prevalence of human papillomavirus and relative risk of prostate cancer: a meta-analysis

L Yang, S Xie, X Feng, Y Chen, T Zheng, M Dai… - Scientific reports, 2015 - nature.com
Despite the increasing number of studies conducted recently to evaluate the association
between HPV infections and the risk of prostate cancer, the results remain inconclusive …

Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older

HL Wong, E Tworkoski, CK Zhou, M Hu, D Thompson… - Vaccine, 2023 - Elsevier
Background Monitoring safety outcomes following COVID-19 vaccination is critical for
understanding vaccine safety especially when used in key populations such as elderly …

Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease

TU Ahearn, S Peisch, A Pettersson, EM Ebot… - …, 2018 - academic.oup.com
Circulating insulin-like growth factor-1 (IGF-1) is consistently associated with prostate cancer
risk. IGF-1 binds to IGF-1 receptor (IGF1R) and insulin receptor (IR), activating cancer …

[HTML][HTML] Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019–2020

K Moll, B Lufkin, KR Fingar, CK Zhou, E Tworkoski… - Vaccine, 2023 - Elsevier
Abstract Background The US Food and Drug Administration (FDA) Biologics Effectiveness
and Safety (BEST) Initiative conducts active surveillance of adverse events of special …